Latest News & Features
Americas
The US Food and Drug Administration has denied Amgen’s petition asking that the so-called patent dance between a biosimilar maker and the product’s innovator be a mandatory requirement. 30 March 2015
Biotechnology
An appeals board at the European Patent Office has said that any patent applications covering a “product-by-process” method for developing plants can be granted. 27 March 2015
Americas
Cancer treatment company Helsinn and pharmaceutical company Roche have sued Hospira for allegedly infringing five patents covering intravenous anti-nausea drug Aloxi. 25 March 2015
Americas
Massachusetts-based biotechnology company ImmunoGen has granted pharmaceutical company Takeda exclusive rights to use its antibody-drug conjugate technology to develop and commercialise cancer drugs. 25 March 2015
Americas
The US Court of Appeals for the Federal Circuit yesterday upheld a district court's decision that pharmaceutical company Exela infringed two patents covering Cadence Pharmaceuticals’s injectable Ofirmev, used for pain relief. 24 March 2015
Asia
The Delhi High Court has granted pharmaceutical company Merck an injunction that prevents Glenmark Pharmaceuticals from making and selling its diabetes drugs Zita and Zitamet. 24 March 2015
Americas
Law firm Latham & Watkins has added to its Washington, DC office with the appointment of patent litigator Casey Dwyer as partner. 24 March 2015
Americas
A judge at the US District Court for the Northern District of California has denied Amgen’s attempt to block entry of a biosimilar version of its drug Neupogen. 23 March 2015
Americas
Bristol-Myers Squibb has sued generic drug maker Mylan for allegedly infringing a patent covering its HIV drug Reyataz. 20 March 2015
Big Pharma
Intellectual property is still seen as a “dirty term” in the EU, the assistant general counsel of pharmaceutical company GlaxoSmithKline has claimed. 19 March 2015